Clinical Trial Update: Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of the GEMOX (gemcitabine and oxaliplatin) combination with vinorelbine in non-small cell lung cancer has completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Sanofi | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED